Totect (Cumberland Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Totect drug offered from Cumberland Pharmaceuticals Inc.. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cumberland Pharmaceuticals Inc.
NON-PROPRIETARY NAME: dexrazoxane hydrochloride
SUBSTANCE NAME: DEXRAZOXANE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-07-25
END MARKETING DATE: 0000-00-00


Totect HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTotect from Cumberland Pharmaceuticals Inc.
LABELER NAME: Cumberland Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2017-07-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66220-110_25c418f4-00b5-471c-9473-e84fa740c4ea
PRODUCT NDC: 66220-110
APPLICATION NUMBER: NDA022025

Other DEXRAZOXANE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Dexrazoxane
Breckenridge Pharmaceutical, Inc.Dexrazoxane
Clinigen Healthcare LtdCardioxane
Cumberland Pharmaceuticals Inc.Totect
Gland Pharma LimitedDexrazoxane
Pharmacia and Upjohn Company LLCZinecard
ThyMoorgan GmbH Pharmazir & Co. K.GDexrazoxane
West-Ward Pharmaceuticals CorpDexrazoxane